Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant amount » significant impact (Expand Search)
significant non » significant gap (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant amount » significant impact (Expand Search)
significant non » significant gap (Expand Search)
-
2621
The characteristics of patient groups were used to prove the method’s applicability.
Published 2025Subjects: -
2622
-
2623
ROS, K<sup>+</sup> efflux and cathepsin B are required for NLRP3 activation.
Published 2025Subjects: -
2624
-
2625
-
2626
-
2627
Differences in health-related quality of life indexes after disease onset between groups.
Published 2025Subjects: -
2628
-
2629
Ba/F3 EML4-ALK<sup>mutants</sup> exhibit variable dose-response to ABT-199 treatment.
Published 2025Subjects: -
2630
-
2631
-
2632
-
2633
-
2634
-
2635
-
2636
-
2637
Molecular docking showed that ABT-199 can fit into active site of ALK<sup>Mutant</sup>.
Published 2025Subjects: -
2638
-
2639
-
2640